START A CONVERSATION
Tell Us What Support You Need
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston CRO team member.
BIOBOSTON CRO SERVICES
BioBoston CRO helps biotechnology, pharmaceutical, medical device, and diagnostic organizations strengthen clinical programs through focused clinical research services. Support can begin with one defined workstream or bring together several specialists around a broader program need.
Our model is designed for sponsors that need experienced planning, writing, regulatory, quality assurance, data, study-management, or project-management support. BioBoston provides the expertise, deliverables, oversight, or coordination defined in the scope.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston CRO team member.
THERAPEUTIC AREAS
BioBoston CRO supports clinical programs across a broad range of therapeutic areas, combining specialized scientific, clinical, regulatory, and quality expertise with flexible CRO support tailored to each program across All Therapeutic Areas.
Breast cancer, lung cancer, prostate cancer, colorectal cancer, ovarian cancer, and other oncology indications
Inflammatory bowel diseases, Crohn’s disease, ulcerative colitis, and other GI indications
Multiple myeloma, lymphomas, leukemias, hemophilia, and other bleeding disorders
CAR-T, gene editing, stem cell therapy, and immunotherapy
Multiple sclerosis, spasticity, stroke, Alzheimer’s, Parkinson’s, and other neurological indications
UTI, CAP/VAP/HAP, skin infections, bacteremia, fungal diseases, sepsis, hepatitis, and other infectious diseases
Oncology, neurology, and other therapeutic areas with a broad range of isotopes and targets
COPD, IPF, asthma, pneumonia, and other respiratory diseases
Allergy, immunology, rheumatology, endocrine and metabolic diseases, cardiology, nephrology and urology, and other indications
WHY BIOBOSTON CRO
Bring experienced clinical, regulatory, quality, data, statistics, writing, and project professionals into the work that requires judgment.
Connect decisions across development strategy, documents, data, quality, vendors, timelines, and budgets instead of solving each issue in isolation.
Use a focused project, an embedded specialist, an independent assessment, an oversight role, or a coordinated multi-workstream engagement.
Define what BioBoston will advise, author, review, manage, resource, oversee, or coordinate, including partner-supported activities when appropriate.
SERVICE NAVIGATOR
Choose the service area that best matches the immediate need. Each page explains the scope, deliverables, process, related services, and next step in more detail.
Clinical and regulatory document authoring, review coordination, and quality control across the development program. FDA Briefing Book Writing, Clinical Study Report Writing, Investigator Brochure Support, Protocol Writing, and Submission Writing.
Statistical strategy, sample size, analysis planning, randomization support, tables, listings, figures, and statistical programming.
Clinical development plans, protocol synopses, endpoint strategy, CRO selection, and early trial budget review.
Regulatory pathway, submission planning, labeling support, and safety and efficacy summary support.
Sponsor oversight, mock FDA inspections, clinical quality management, GCP CAPA support, GCP audits, and TMF audits.
Data-management plan review, EDC vendor qualification, EDC build and database design, eCRF review, and data-quality oversight.
Clinical operations strategy, vendor evaluation, sponsor-side oversight, independent assessment, expert resourcing, and partner-supported coordination for Site Feasibility, Site Selection, Site Startup, Patient Recruitment, Patient Retention, Clinical Monitoring, Risk-Based Monitoring, Medical Monitoring and Clinical Supply Coordination.
Clinical project management, timeline management, budget tracking, vendor governance, trial rescue, and responsibility matrices.
COMMON TRIGGERS
Sponsors often seek clinical trial support when the problem crosses functional boundaries or when internal leaders need experienced capacity without adding a permanent role.
Begin with the project situation. BioBoston CRO can help separate the immediate deliverable from the related planning, quality, data, regulatory, or management dependencies.
HOW SUPPORT IS DELIVERED
BioBoston CRO is positioned as a CRO services and clinical research service provider. Each engagement defines the delivery model before work begins so the sponsor, BioBoston specialists, CROs, vendors, and partners understand their responsibilities.
Depending on the need, BioBoston CRO may advise the sponsor, produce a defined deliverable, embed an experienced specialist, independently assess a program, oversee outsourced activities, coordinate multiple contributors, or support delivery through qualified partners.
Clarify options, decisions, sequencing, risks, roles, and the work needed before execution.
Strengthen sponsor governance, evaluate performance, manage issues, and coordinate partner-supported activities.
Author, review, assess, or build an agreed output with a documented scope, inputs, review process, and acceptance criteria.
Add senior capacity to the sponsor team for a defined period, workstream, milestone, or governance role.
CONNECTED WORKSTREAMS
Translate approved strategy, evidence, and cross-functional input into clear clinical and regulatory documents. The service pillar routes document-specific needs to submission writing, Clinical Study Report writing, FDA briefing book writing, Investigator Brochure support, and protocol writing.
Support statistical decisions that affect study design, sample size, analysis planning, randomization, outputs, and programming.
Build the development roadmap and early study framework, including clinical development plans, protocol synopses, endpoint strategy, CRO selection, and trial budget review.
Clarify pathway and submission decisions, plan application sequencing, support labeling, and develop relevant safety and efficacy summaries. Regulatory strategy is kept separate from document authoring ownership.
Strengthen sponsor oversight, inspection readiness, clinical quality systems, GCP audit coverage, TMF quality, and clinical CAPA work with evidence that can withstand scrutiny.
Improve data-planning documents, EDC vendor qualification, database design, electronic case report form quality, edit checks, query oversight, reconciliation, lock readiness, and data-security planning.
Support operational strategy, feasibility, vendor evaluation, sponsor-side oversight, expert resourcing, quality review, and partner-supported coordination while keeping the exact delivery model transparent.
Create the governance, schedules, budget controls, vendor management, recovery plans, and responsibility matrices needed to keep a multi-party clinical program moving.
WAYS TO ENGAGE
A defined assessment, plan, document, audit, review, build, or remediation effort with agreed deliverables and milestones.
Supplemental senior capacity for a function, milestone, governance role, or temporary workload increase.
An objective review of quality, readiness, vendor performance, data practices, documents, or program controls.
Coordinated specialists working across connected workstreams with one delivery framework and clear sponsor interfaces.
Targeted recovery when a study, document program, vendor relationship, inspection-readiness effort, timeline, or budget is already at risk.
PROGRAM ALIGNMENT
Clinical programs rarely fail at a single functional boundary. A protocol decision affects statistics, data collection, monitoring, safety review, timelines, budgets, vendors, and future submissions. BioBoston’s role can include identifying those dependencies early and assigning each decision to the correct owner.
Define the sponsor decision, deliverable, risk, and milestone that triggered the engagement.
Map the affected functions, vendors, source documents, review roles, and approval points.
Separate strategic decisions from document authoring, operational execution, quality oversight, and project control.
Create a practical work plan with responsibilities, dependencies, review cycles, and escalation paths.
Track decisions and outputs through completion while preserving sponsor approval and accountability.
TRUST AND QUALIFICATION
BioBoston CRO can assemble experienced specialists around the clinical, regulatory, quality, data, statistical, writing, and management questions that require judgment. The expert profile matches the product type, development stage, deliverable, regulatory context, and delivery model.
The BioBoston organization has been recognized by Global Health & Pharma (GHP) with multiple industry awards, including:
Best Life Science Advisory Firm – New England — 2024 & 2025
Most Trusted Pharma & Biotech Advisory – USA — 2025
Best Life Science & Medical Device Advisory Firm – Massachusetts — 2025
Life Sciences Quality & Regulatory Excellence Partner of the Year — 2026
GHP Client Support Excellence Award — 2026
Our team brings experience across clinical operations, regulatory affairs, quality, medical writing, biostatistics, data management, clinical study management, and project management to support programs throughout clinical development.
PRACTICAL GUIDANCE
A planned buyer guide covering service-model fit, responsibility boundaries, oversight expectations, and vendor-selection questions.
A planned educational resource on document planning, writer selection, review models, source inputs, and quality control.
A planned guide that answers informational protocol-development questions and links to the Protocol Writing commercial page.
FAQs
BioBoston’s approved CRO architecture includes Medical Writing, Biostatistics, Product Development Planning, Regulatory Affairs, Clinical Quality Assurance Services, Clinical Data Management, Clinical Study Management, and Project Management. Each engagement is scoped around the specific workstream, deliverable, oversight need, or program risk.
Yes. A sponsor may engage BioBoston CRO for one focused need, such as a clinical development plan, protocol, statistical analysis plan, regulatory pathway, GCP audit, data-management review, vendor-governance issue, or timeline recovery. Related dependencies can be identified without expanding the scope unnecessarily.
Yes. BioBoston CRO can support the sponsor side of an outsourced model by clarifying responsibilities, reviewing deliverables, strengthening oversight evidence, evaluating performance, coordinating issues, or supplying a specialist that complements the existing team.
The model is especially relevant to emerging, virtual, and growing biotechnology or medical-product organizations; sponsors with lean internal teams; established companies facing a specialized gap; and programs that need independent expertise across clinical, regulatory, quality, data, or project functions.
Contact BioBoston CRO when an important decision, document, vendor, inspection-readiness activity, data milestone, timeline, or budget is beginning to create risk. Earlier involvement usually creates more options, but rescue and remediation support can also be scoped when the problem is already active.
NEXT STEP
A useful first discussion does not require a finished scope. Share the project stage, the immediate pressure point, the teams or vendors involved, and the milestone you are trying to protect. BioBoston can help determine whether the need belongs to one service area or requires coordinated support.
Describe the workstream, timing, and decision that needs support. We will review the request and follow up regarding fit and possible next steps.